PCTs failing to involve public in drug decisions

Primary care trusts are failing to effectively involve the public in decisions over drugs not approved by the National Institute for Health and Clinical Excellence, according to a Picker Institute review.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here